JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flanagan, P G
Right arrow Articles by Findlay, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flanagan, P G
Right arrow Articles by Findlay, G
Related Collections
Right arrow Other Infectious Diseases
Right arrow Critical Care / Intensive Care
Right arrow Other respiratory infections
J Clin Pathol 2001; 54:107-110
© 2001 Journal of Clinical Pathology

Diagnosis of Gram negative, ventilator associated pneumonia by assaying endotoxin in bronchial lavage fluid

P G Flanagan1, S K Jackson2, G Findlay3

1 Department of Medical Microbiology, Llandough Hospital, Penlan Road, Penarth, Vale of Glamorgan, CF64 2XX, UK
2 Department of Medical Microbiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK
3 Intensive Care Unit, University Hospital of Wales, Cardiff CF4 4XW, UK

Dr Flanagan paul.flanagan{at}phls.wales.nhs.uk Aim—To investigate the usefulness of assaying endotoxin in non-directed bronchial lavage fluid (NBL), bronchoscopic bronchoalveolar lavage fluid (BAL), and sera as a means of diagnosing Gram negative, ventilator associated pneumonia.

Methods—Samples from 64 patients were investigated. Fifty nine BALs and 92 NBLs were assayed in total including specimens taken during 28 episodes of clinical ventilator associated pneumonia (VAP).

Results—The concentration of endotoxin in BAL from patients with VAP developing within four days of commencing ventilation was significantly higher than in those without VAP (p = 0.015). There was no significant difference in endotoxin concentration in NBL or serum when comparing patients with and without VAP. A BAL endotoxin concentration of 6 EU/ml yielded the optimal operating characteristics (sensitivity, 81%; specificity, 87%; positive predictive value, 67%; negative predictive value, 95%). However, Gram stain of BAL provided the same information as quickly as the endotoxin assay and is considerably cheaper.

Conclusions—Despite its accuracy and rapidity, the BAL endotoxin assay must be shown to alter clinical management and patient outcome to be cost effective.

Key Words: ventilator associated pneumonia • bronchoalveolar lavage • non-bronchoscopic lavage • endotoxin




This article has been cited by other articles:


Home page
Innate ImmunityHome page
V. B. Serikov, H. Choi, K. Schmiel, C. Skaggs, N.W. Fleming, R. Wu, and J. H. Widdicombe
Endotoxin induces leukocyte transmigration and changes in permeability of the airway epithelium via protein-kinase C and extracellular regulated kinase activation
Innate Immunity, February 1, 2004; 10(1): 55 - 65.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Chastre and J.-Y. Fagon
Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.